Startup
Developing a non-opioid drug providing 24-28 hours of effective pain relief
Programs: CSIRO (ON Accelerate 9)
Every investor coverage indicates participated in a round Enhanced Analgesics raised.
Companies Enhanced Analgesics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Enhanced Analgesics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
CSIRO's ninth ON accelerator cohort of eleven research teams has completed the program, with three members winning grants, two filing patents, and individual awards announced.
CSIRO's ON Accelerate program presents its ninth intake of eleven research startups, drawn from universities nationwide and the agency itself, spanning biotech, healthcare and sustainability, at a Melbourne showcase.